Kunming Longjin Pharmaceutical Co.,Ltd.’s Net Profit Dropped 42.9% in First Quarter of 2022

Kunming Longjin Pharmaceutical Co.,Ltd. (昆明龙津药业股份有限公司) (002750.SZ) reported a net profit of 689,640 yuan in the first quarter of 2022, down 42.9% year-on-year.

Meanwhile, the company posted 47.6 million yuan in revenue, down 76.9% year-on-year.

At the end of the reporting period, it had 817.2 million yuan in total assets and 138.3 million yuan in total liabilities, with a liability-to-asset ratio of 16.9%.